ADTX Aditxt, Inc.


$ 5.36 $ -0.43 (-7.54 %)    

Friday, 07-Nov-2025 19:49:02 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ na
$ 5.70
$ 5.10 x 2
$ 6.10 x 1
$ 5.00 - $ 5.75
$ 5.00 - $ 11,941.28
61,696
na
99,133
$ 2.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aditxts-pearsanta-begins-enrollment-in-clinical-study-evaluating-mitomic-endometriosis-test-blood-based-diagnostic-designed-to-aid-in-early-detection-of-endometriosis

Prospective study to evaluate diagnostic performance and generate real-world data for the Mitomic® Endometriosis Test, a non-in...

Core News & Articles

-- Special Meeting to be held on September 26, 2025 --SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders tod...

 aditxt-plans-fda-submission-for-first-in-human-trials-in-type-1-diabetes-and-stiff-person-syndrome-in-early-2026

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for e...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION